BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31585423)

  • 1. Moyamoya disease versus moyamoya syndrome: comparison of presentation and outcome in 338 hemispheres.
    Feghali J; Xu R; Yang W; Liew JA; Blakeley J; Ahn ES; Tamargo RJ; Huang J
    J Neurosurg; 2019 Oct; 133(5):1441-1449. PubMed ID: 31585423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
    Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
    J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Clinical and Radiographic Phenotypes in Pediatric Patients With Moyamoya.
    Kaseka ML; Slim M; Muthusami P; Dirks PB; Westmacott R; Kassner A; Bhathal I; Williams S; Shroff M; Logan W; Moharir M; MacGregor DL; Pulcine E; deVeber GA; Dlamini N
    Pediatr Neurol; 2021 Jul; 120():18-26. PubMed ID: 33962345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between moyamoya disease and moyamoya syndrome in Israel.
    Schwartzmann Y; Spektor S; Moscovici S; Jubran H; Metanis I; Jouaba T; Cohen JE; Gomori JM; Leker RR
    J Stroke Cerebrovasc Dis; 2024 Apr; 33(4):107635. PubMed ID: 38342272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
    Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failures in Revascularization for Pediatric Moyamoya Disease and Syndrome: A Scoping Review.
    Shlobin NA; Frankel HG; Lam S
    World Neurosurg; 2021 May; 149():204-214.e1. PubMed ID: 33618047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial phenotypes in moyamoya disease: a comparative analysis of clinical presentation and natural history in a single multiethnic cohort of 250 hemispheres.
    Feghali J; Xu R; Yang W; Liew J; Tamargo RJ; Marsh EB; Huang J
    J Neurosurg; 2019 Oct; 133(6):1766-1772. PubMed ID: 31585430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Vessel Wall MRI Investigation in Patients With Moyamoya or Quasi-Moyamoya Disease: Diagnosis, Features, and Outcomes.
    Yu LB; Shen M; Zhang Q; Zhang D
    J Craniofac Surg; 2024 Jan-Feb 01; 35(1):e24-e28. PubMed ID: 37622552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Surgery for Moyamoya Is Not Associated with Worse Outcomes: Analysis of a North American Adult Cohort.
    Reed LK; Soto JM; Benardete EA
    World Neurosurg; 2023 Jun; 174():e53-e61. PubMed ID: 36871651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Treatment for Patients with Moyamoya Syndrome and Type 1 Neurofibromatosis.
    Porras JL; Yang W; Garzon-Muvdi T; Xu R; Blakeley J; Belzberg A; Caplan JM; Khalid S; Colby GP; Coon AL; Tamargo RJ; Ahn ES; Huang J
    World Neurosurg; 2017 Mar; 99():19-25. PubMed ID: 27876659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of pro-thrombotic conditions in adult patients with moyamoya disease and moyamoya syndrome: a single center study.
    Larson A; Rinaldo L; Lanzino G; Klaas JP
    Acta Neurochir (Wien); 2020 Aug; 162(8):1853-1859. PubMed ID: 32462312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirect revascularization vs. non-surgical treatment for Moyamoya disease and Moyamoya syndrome: A comparative effectiveness study.
    Wang Y; Li M; Wang J
    Front Neurol; 2022; 13():1041886. PubMed ID: 36601296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing Surgical Outcomes in a Multiethnic Cohort Suggest Racial Phenotypes in Moyamoya Disease.
    Feghali J; Xu R; Yang W; Liew J; Tamargo RJ; Marsh EB; Huang J
    World Neurosurg; 2019 Aug; 128():e865-e872. PubMed ID: 31082553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population.
    Khan NI; Saherwala AA; Chen M; Salehian S; Salahuddin H; Welch BG; Pinho MC; Shang T
    Cerebrovasc Dis Extra; 2019; 9(3):139-147. PubMed ID: 31830749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric Moyamoya Disease and Syndrome in Italy: A Multicenter Cohort.
    Po' C; Nosadini M; Zedde M; Pascarella R; Mirone G; Cicala D; Rosati A; Cosi A; Toldo I; Colombatti R; Martelli P; Iodice A; Accorsi P; Giordano L; Savasta S; Foiadelli T; Sanfilippo G; Lafe E; Thyrion FZ; Polonara G; Campa S; Raviglione F; Scelsa B; Bova SM; Greco F; Cordelli DM; Cirillo L; Toni F; Baro V; Causin F; Frigo AC; Suppiej A; Sainati L; Azzolina D; Agostini M; Cesaroni E; De Carlo L; Di Rosa G; Esposito G; Grazian L; Morini G; Nicita F; Operto FF; Pruna D; Ragazzi P; Rollo M; Spalice A; Striano P; Skabar A; Lanterna LA; Carai A; Marras CE; Manara R; Sartori S
    Front Pediatr; 2022; 10():892445. PubMed ID: 35601411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More Precise Imaging Analysis and Diagnosis of Moyamoya Disease and Moyamoya Syndrome Using High-Resolution Magnetic Resonance Imaging.
    Yu LB; He H; Zhao JZ; Wang R; Zhang Q; Shi ZY; Shao JS; Zhang D
    World Neurosurg; 2016 Dec; 96():252-260. PubMed ID: 27576769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. dl-3-n-butylphthalide for alleviation of neurological deficit after combined extracranial-intracranial revascularization for moyamoya disease: a propensity score-matched analysis.
    Li Z; Lu J; Ma L; Wu C; Xu Z; Chen X; Ye X; Wang R; Zhao Y
    J Neurosurg; 2019 Feb; 132(2):421-433. PubMed ID: 30771781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and long-term outcomes of moyamoya syndrome associated with neurofibromatosis type 1.
    Han C; Yang WZ; Zhang HT; Ye T; Duan L
    J Clin Neurosci; 2015 Feb; 22(2):286-90. PubMed ID: 25443089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
    Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
    J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective study.
    Aldana PR; Hanel RA; Piatt J; Han SH; Bansal MM; Schultz C; Gauger C; Pederson JM; Iii JCW; Hulbert ML; Jordan LC; Qureshi A; Garrity K; Robert AP; Hatem A; Stein J; Beydler E; Adelson PD; Greene S; Grabb P; Johnston J; Lang SS; Leonard J; Magge SN; Scott A; Shah S; Smith ER; Smith J; Strahle J; Vadivelu S; Webb J; Wrubel D
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30336. PubMed ID: 37057741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.